Organotypic endothelial adhesion molecules are key for Trypanosoma brucei tropism and virulence by De Niz, Mariana et al.
ArticleOrganotypic endothelial adhesion molecules are key
for Trypanosoma brucei tropism and virulenceGraphical abstractHighlightsd Our study investigates the blood vasculature for T. brucei
reservoir establishment
d We show the pancreas is a large extravascular reservoir
d We establish that T. brucei tropism is linked to organotypic
adhesion molecules
d Interfering with adhesion molecules impacts parasite
virulence and host survivalDe Niz et al., 2021, Cell Reports 36, 109741
September 21, 2021 ª 2021 The Author(s).
https://doi.org/10.1016/j.celrep.2021.109741Authors
Mariana De Niz, Daniela Brás,
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https://doi.org/10.1016/j.celrep.2021.109741SUMMARYTrypanosoma brucei is responsible for lethal diseases in humans and cattle in Sub-Saharan Africa. These
extracellular parasites extravasate from the blood circulation into several tissues. The importance of the
vasculature in tissue tropism is poorly understood. Using intravital imaging and bioluminescence, we
observe that gonadal white adipose tissue and pancreas are the two main parasite reservoirs. We show
that reservoir establishment happens before vascular permeability is compromised, suggesting that extrav-
asation is an active mechanism. Blocking endothelial surface adhesion molecules (E-selectin, P-selectins, or
ICAM2) significantly reduces extravascular parasite density in all organs and delays host lethality. Remark-
ably, blocking CD36 has a specific effect on adipose tissue tropism that is sufficient to delay lethality, sug-
gesting that establishment of the adipose tissue reservoir is necessary for parasite virulence. This work
demonstrates the importance of the vasculature in a T. brucei infection and identifies organ-specific adhe-
sion molecules as key players for tissue tropism.INTRODUCTION
Tissue-specific tropism within vertebrate hosts has been the
focus of great interest in the field of parasitology in recent years.
However, the cellular andmolecular adaptations that allow para-
site tropism are still poorly understood. For many parasites,
tropism to specific organs is an essential step of their life cycle,
because the organs provide a niche for persistence, latency or
dormancy, massive replication and/or growth, protection from
the host immune responses, or differentiation into alternative
stages essential for completion of the life cycle, among others
(Boyett and Hsieh, 2014; Fernandes and Andrews, 2012; Guérin
and Striepen, 2020; Lima and Lodoen, 2019; Onyilagha and
Uzonna, 2019; Prudêncio et al., 2006; Rénia andGoh, 2016; Silva
Pereira et al., 2019; Venugopal et al., 2020).
Trypanosoma brucei is a parasitic organism transmitted by tse-
tse flies (Glossina spp.), responsible for human African trypanoso-
miasis (HAT) in humans and nagana in other mammals. It requires
two hosts to live and reproduce, namely, the insect vector and the
mammalian host (Centers for Disease Control and Prevention,
2019). T. brucei invades the bloodstream and lymph and dissem-
inates across the host body (Kr€uger and Engstler, 2018). The ad-
ipose tissue, skin, and brain have been identified as importantCel
This is an open access article under the CC BY-Nextravascular reservoirs of T. brucei because of the numbers of
parasites harbored, the role they play in parasite transmission,
or the associated pathology, respectively (Casas-Sánchez and
Acosta-Serrano, 2016; De Niz et al., 2019a–c; Silva Pereira
et al., 2019). Yet, the relative contribution of parasite tissue reser-
voirs to overall parasitemia and disease outcome is unclear.
The relevance of the vascular endothelium for tropismandpara-
site dissemination has been studied in detail in the context of other
parasites. For instance, Plasmodium-infected red blood cells
(RBCs) undergo sequestration in the vasculature of several or-
gans. Multiple endothelial cell (EC) receptors, including intercel-
lular adhesion molecule 1 (ICAM1), endothelial protein C receptor
(EPCR), platelet/endothelial cell adhesion molecule 1 (PECAM1),
and CD36, have been associated with sequestration in specific
tissues in both human and rodent malaria infections (Fonager
et al., 2012; Hviid and Jensen, 2015; De Niz et al., 2016; Smith
et al., 2001). While Plasmodium asexual blood stages are unable
to cross the vascular endothelium, T. brucei extravasation has
been studied in the brain. Two key findings include that a trypano-
some-derived cathepsin L-like cysteine protease (brucipain) is
required for traversal of the brain-blood barrier, and that vascular
permeability does not correlate with parasite dissemination in the




OPEN ACCESSHere, we used intravital imaging to study the role of blood ves-
sels in the establishment of T. brucei tissue reservoirs in vivo. We
have characterized the dynamics of host-parasite interactions
with the vascular endothelium and its relationship to parasite
tropism. We identified the pancreas as another reservoir for
T. brucei, which, together with the gonadal white adipose tissue
(g-WAT), constitutes the organs with highest parasite density.
We showed that g-WAT and pancreatic tropism depend on
several adhesion molecules expressed at the surface of ECs.
We found that extravasation into the adipose tissue is specif-
ically affected by the adhesion molecule CD36, and we demon-
strated that the establishment of this reservoir is a key virulence
mechanism with great impact in disease outcome. Our analysis
shows that the vasculature plays an essential role in T. brucei
infection, and that the establishment of tissue reservoirs in-
creases the fitness of parasites and disease severity.
RESULTS
g-WAT tissue and pancreas are largest reservoirs of
extravascular parasites
Little is known about the dynamics of T. brucei reservoir estab-
lishment in vivo. To evaluate parasite distribution in mice with
high temporal resolution, we used a transgenic parasite line ex-
pressing the red-shifted firefly luciferase PpyREH9 and TdTo-
mato fused with a TY1 tag (Calvo-Alvarez et al., 2018). We
injected 2 3 103 parasites intraperitoneally in each mouse, and
we followed the parasitemia in vivo in C57BL/6 and C57BL/6 Al-
bino mice, the latter being a more suitable model to measure
bioluminescence (Curtis et al., 2011; Doyle et al., 2004) (Fig-
ure S1A, left panel). In both mouse strains, we observed high
blood parasitemia at days 5–8, and then later in infection, as pre-
viously reported (Calvo-Alvarez et al., 2018). Both strains of mice
showed similar survival times, with 50% survival being reached
by days 22–23 post-infection (Figure S1A, middle panel). There-
fore, we limited the infection to day 20 for all subsequent
experiments.
The relative whole-body bioluminescence measured in Albino
mice (Figure 1A) correlated very well with blood parasitemia (R2 =
0.82, p < 0.001) (Figure S1A, right panel). To determine relative
parasite density in individual organs, we dissected each organ
following injection of luciferin and performed ex vivo biolumines-
cence imaging (Figures 1B and 1C; Figure S1B). Three white and
two brown adipose tissues (WATs and BATs, respectively) were
collected (schematic shown in Figure S1C). Animals were not
perfused prior to organ excision; therefore, the signal measured
includes both intravascular and extravascular parasites (Fig-
ure 1C; Figure S1B). g-WAT, pancreas, and lungs (marked with
arrows, Figure 1C) were the organs that presented the highest
bioluminescence values throughout infection (Figure 1C; Fig-
ure S1B). For quantitative comparison, we show pooled biolumi-
nescence values of all organs during the first peak of parasitemia
(days 5–8 post-infection) (Figure 1D). The lungs, pancreas, and
g-WAT showed around 30-fold higher bioluminescence than
the average of other organs. Without perfusion, among adipose
tissues, bioluminescence signal in the g-WAT was around 60- to
250-fold higher than other WAT depots (p < 0.001). Global com-
parisons between WAT and BAT depots showed that biolumi-2 Cell Reports 36, 109741, September 21, 2021nescence in BAT depots was significantly lower than WAT
depots (p = 0.04) (Figure S1C). The pancreas was the organ
with the highest accumulated daily intensity, being on average
2.8-fold higher than g-WAT and 22-fold higher than lungs
considering the 20 days of infection. In the skin, we identified
high heterogeneity in parasite distribution (Figure S1D), whereby
some regions are highly enriched in parasites and others are not.
This heterogeneity is consistent with previous observations (Ca-
pewell et al., 2016).
In the bloodstream, parasites are at very high concentrations
(Figure S1A). To discriminate the bioluminescent signal between
intravascular and extravascular compartments, we perfused
mice prior to measuring bioluminescence to remove signal
from intravascular parasites on day 6 post-infection (Figure 1E).
In perfusedmice, only g-WAT and pancreas showed significantly
high bioluminescence. Upon perfusion, g-WAT was 200- to
4,800-fold higher than the four other WAT or BAT depots (p <
0.001 for all comparisons with g-WAT). At day 6 post-infection,
the pancreas was equally enriched as the g-WAT (p = 0.25)
and 1,000-fold higher than lungs (p < 0.001). Notably, the signal
intensity in lungs decreased 200-fold after perfusion compared
with non-perfusedmice (p < 0.001) (Figures 1D and 1E), suggest-
ing that most parasites in the lungs remained intravascular.
These results were independent of the route of infection used
(Figure S1E).
To confirm the bioluminescence results, we determined the
intravascular and extravascular location of parasites in each or-
gan at a single-cell level, using intravital microscopy (IVM) and
ex vivo confocal microscopy (Figures 1F–1J; Video S1). Intravas-
cular parasite density (parasites/10 mm2) measured by intravital
microscopy showed a similar pattern of parasite density in all or-
gans, with two parasitemia ‘‘waves’’ in peripheral blood (Fig-
ure 1G), consistent with measurements performed by hemocy-
tometer (Figure 1C; Figure S1A). Quantification of intravascular
and extravascular parasites during the first parasitemia wave
(days 5–8) (Figures 1I and IJ) confirmed a significant enrichment
in the g-WAT and pancreas. Throughout infection, in total, the
number of parasites per 10mm2 found in the extravascular space
of g-WAT and pancreas corresponds to around 40% of the sum
of extravascular parasites counted per 10 mm2 in the 13 organs,
while the three WAT depots together contribute to 48%.
The intravital imaging analysis identified four different patterns
of intravascular and extravascular T. brucei distribution across
organs (Figures 1G–1J; Figure S2). In group 1 (Figure S2A), there
is proportionally more parasites in the extravascular space (blue)
than intravascularly (red) throughout most of the infection. Group
2 (Figure S2B) has a pattern similar to group 1, in which the intra-
vascular and extravascular compartments present two waves of
parasite populations with a minimum around day 11, with the dif-
ference being that group 2 has consistently more intravascular
than extravascular parasites. Given the consistency of patterns
between the BAT and WAT groups, henceforth we use only
one representative of each tissue category (gonadal for WAT
and interscapular for BAT [i.e., isc-BAT]). In a third group (Fig-
ure S2C), the vast majority of parasites reside inside vessels,
with a small population colonizing the extravascular space
mostly after the first peak of blood parasitemia. Finally, the last






Figure 1. Identification of WAT and pancreas as
the two main T. brucei extravascular reservoirs
(A) Representative images of whole-body biolumines-
cence in ventral (right panel) and dorsal (left panel)
positions of a mouse infected with luciferase-ex-
pressing T. brucei at day 6 post-infection.
(B) Representative images of non-perfused organs
collected from infected mice (day 6 post-infection).
(C) Mean bioluminescence (extravascular and intra-
vascular parasites) values of individual mouse organs
expressed as log10 light units per tissue area.
(D and E) Mean parasite density of individual organs
during the first wave of parasitemia (days [d] 5–8) in
non-perfused mice (D) and at day 6 post-infection in
perfused mice (E) measured by bioluminescence (log10
light units per tissue area). All bioluminescence quan-
tifications (A–D) correspond to values obtained from a
minimum of nine mice.
(F) Immunofluorescence representative images ob-
tained by intravital live imaging of parasites (TdTomato
reporter, red) in g-WAT, pancreas, brain, and spleen at
d3, d6 and d10 post-infection. Vessels are labeled with
anti-CD31 antibody (yellow), interstitial space with
FITC-Dextran, and nuclei with Hoechst (blue). Dyes
and antibodies were administered by retroorbital
intravenous injection 10–30 min prior to imaging. Scale
bars, 50 mm.
(G and H) Heatmap of parasite density (number of
parasites per tissue area) inside (G) or outside vessels
(H). Dotted white lines denote the beginning of extra-
vascular colonization (S [start], day 2), first peak of
infection (P1, day 6), and the end of the first wave of
parasitemia (E1 [end], day 10). For each day of infec-
tion, at least 100 fields of view were quantified, and the
mean value is shown in the heatmap.
(I and J)Mean parasite density (number of parasites per
tissue area) of individual organs inside (I) or outside (J)
vessels during the first wave of parasitemia (d5–8),
measured by intravital imaging.
For all relevant figures, dotted red lines show the in-
terquartile range considering all organs. Organs above
the upper threshold are considered significantly en-
riched, using an ANOVA statistical test. ***p < 0.001,
**p < 0.01, *p < 0.05. All relevant data used to generate
this figure are included in Data S1 (tabs 1–4). p/s,
photons per second. See also Figures S1 and S2 and
Videos S1 and S2.






Figure 2. Changes in organ vascular den-
sity during T. brucei infection
(A) Vasculature is labeled with an antibody anti-
CD31 (yellow), while nuclei are labeled by Hoechst
(blue) upon retroorbital injection. Vascular density
corresponds to the percentage of the imaged area
filled with blood vessels based on the marker
CD31 (middle and right panels). Scale bar, 50 mm.
(B) Heatmap of mean vascular density throughout
20 days of infection. At least 100 fields of view per
day.
(C) Boxplot of mean vascular density for d5–8
(black) and d15–18 (red) depicted in (B).
For all graphs, significance is shown as ***p <
0.001, **p < 0.01, or *p < 0.05. All relevant data
used to generate this figure are included in Data S1
(tabs 6 and 7). See also Figure S3.
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OPEN ACCESSextravascularization of parasites prior to the peak in the periph-
eral blood but little enrichment later in infection.
Altogether, these results indicate that parasite distribution in
intravascular and extravascular spaces is very heterogenous
across organs and varies with time. Importantly, in terms of
establishment of an early tissue reservoir, we conclude that
g-WAT and pancreas parasite reservoirs are established since
day 3 post-infection, and that both remain the most parasitized
organs throughout infection.
T. brucei enrichment in the pancreas and WATs is not
correlated to vascular density
Next, we investigated the reasons for g-WAT and pancreatic
tropism. First, we explored if there were differences in vascular
density between organs. Vascular density indicates the percent-
age of the imaged area filled with blood vessels (marked by
CD31/PECAM1, an EC receptor, or fluorescein isothiocyanate
[FITC]-Dextran, a large polysaccharide that stays inside vessels
unless there is increased vascular permeability) (Figure 2A).
In non-infected animals, we found that organs such as brain,
lungs, liver, spleen, and lymph nodes are highly vascularized
(30%–60%of their area consists of vessels), while adipose tissue
depots, pancreas, heart, and kidneys are less vascularized
(12%–30%) (Figures 2B and 2C; Figure S3), consistent with the
literature (Cook, 1965). Figure 2C depicts vascular density during
the first parasitemia wave (days 5–8, black boxes) and the last
parasitemia wave (days 15–18, red boxes). During infection,
vascular density remained unchanged in most organs, including4 Cell Reports 36, 109741, September 21, 2021pancreas. In contrast, vascular density in
g-WAT significantly increased from 13%
at day 1 to 49% at day 20 post-infection
(Figure 2B; Figure S3), and it significantly
decreased in spleen and lymph nodes
from 51% and 36%, respectively at day
1 to 16% and 8%, respectively, at day
20 post-infection (Figure 2B; Figure S3).
The increase in vascular density observed
in the g-WAT coincides with andmight be
caused by tissue shrinkage by up to 82%
probably because of extensive lipolysisduring infection (also observed in other WATs) (Trindade et al.,
2016). Conversely, the decrease in vascular density observed in
thespleenand lymphnodescouldbebecauseof thedramatic tis-
sue enlargement (increase of 60% and 210%) that these organs
undergo as infection progresses.
When we compared the variation over time of the organ
vascular density with the organ extravascular parasite density
during 20 days of infection (Figure 1H), we found a significant
correlation for some organs (g-WAT, pancreas, kidneys, isc-
BAT, and spleen), but not others (heart, brain, lungs, liver, and
lymph nodes). However, when we considered whether vascular
density correlated with reservoir establishment (i.e., considering
extravascular parasite density only the first 6 days of infection),
we found only a significant correlation for the spleen (R2 =
0.92, p < 0.01), whereas the g-WAT (R2 = 0.13, p = 0.54) and
pancreas (R2 = 0.006, p = 0.9) showed no strong correlation.
Altogether, we conclude that vascular density is not the reason
whyWAT and pancreas are the main reservoirs early in infection.
Parasite distribution across blood vessels is
heterogeneous
Capillaries and post-capillary venules of several organs have
been shown as important locations for Plasmodium sequestra-
tion (Franke-Fayard et al., 2010). Thus, we asked whether the
type of vessel allowing parasite traversal is important for
T. brucei tropism. In mammals, the vasculature is comprised of
vessels of different diameters, of either arterial or venous origin







Figure 3. Distribution of T. brucei across arterial and venous vasculature is organ specific
(A) Schematic of arterial and venous vasculature, their deriving branches, and respective diameters.
(B) Representative microscopy images of carboxyfluorescein diacetate succinimidyl ester (CFDA-SE)- and 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-
one) succinimidyl ester (DDAO-SE)-labeled RBCs. Parasite concentration was calculated as the number of parasites relative to labeled RBCs. Scale bars, 20 mm.
(C) Representative immunofluorescence images show arteries as Ephrin B2-stained vessels, while veins are Ephrin B4-stained vessels. CFDA-SE-labeled RBCs
are shown in green (marked by arrows). Scale bars, 50 mm.
(D) Violin plots of global parasite concentration relative to RBC in arterial or venous vasculature for the 10 organs analyzed in this study (green dotted line indicates
that there are 100 parasites per 100 RBCs). Significance relative to RBC normalizers is shown as green asterisks.
(E–H) Heatmaps of parasite distribution in vasculature, relative to labeled RBCs. Panels are divided in arterial and venous vasculature. Violin plots of parasite
concentration relative to RBC according to vessel diameter and vessel type. Data shown in the heatmaps and violon plots refer to the representative organ of each
group, which is underlined.
For each day of infection, parasites were quantified in at least 100 fields of view. Significance is defined as follows: ***p < 0.001, **p < 0.01, or *p < 0.05. All relevant
data used to generate this figure are included in Data S1 (tabs 8–9). See also Figures S4 and S5.






OPEN ACCESShypothesized that in the WAT and pancreas, parasites may
accumulate in specific vessels, which could favor crossing
from the blood into the extravascular space. To address this
question, we injected uninfected and infected mice with exoge-
nously labeled RBCs (as the basis for normalization for quantifi-
cations) and monitored their distribution across all vessel types,
which were marked either with the pan-EC marker CD31, the
arterial marker Ephrin B2, or the venous marker EphB4, conju-
gated to the Alexa 647 fluorophore (Figure 3B). It has been
shown that the distribution of RBCs is proportional to the caliber
and hemodynamics in each vessel (Carlson et al., 2008; Chien
et al., 1966; Coppola and Caro, 2009; Secomb, 2016). For
each day of the infection and for each organ, we surgically
stopped blood flow and we quantified the number of parasites
relative to the number of labeled RBCs. Vessels were classified
according to their caliber either considering the total vasculature
(Figure S4) or by venous and arterial identity (Figures 3E–3H). The
longitudinal results of parasite concentration in each type of
vessel are displayed as heatmaps, while the overall distribution
for each condition is represented by violins plots (Figure 3; Fig-
ures S4 and S5).
Vessel caliber was the most important variable that contrib-
uted to heterogenous parasite distribution in the vasculature,
when looking at total vasculature. We identified four phenotypes
of parasite enrichment across organs (shown in Figure S4):
group 1, enrichment in medium and small vessels (Figure S4B)
in the brain and g-WAT; group 2, enrichment in all vessels (Fig-
ure S4C) in the pancreas and lungs; group 3, enrichment in me-
dium and large vessels (Figure S4D) in the heart, kidneys, and
isc-BAT; and group 4, no relative enrichment (Figure S4E) in
the liver, spleen, and lymph nodes.
When taking into account arterial and venous identity, across
the 20 days of infection, we saw that in g-WAT, parasite concen-
tration is similar in arteries and veins (p = 0.12), as is the case also
for the brain (p = 0.16), lungs (p = 0.14), isc-BAT (p = 0.93), liver
(p = 0.68), spleen (p = 0.74), and lymph nodes (p = 0.74). In
contrast, in pancreas (p = 0.02), heart (p < 0.001), and kidneys
(p = 0002), parasites were globally more concentrated in arterial
vessels (Figure 3D).
In g-WAT (Figure 3E), parasite concentration was highest in
vessels of small and medium caliber of both arterial and venous
identity, while in the brain the enrichment was mostly in arterial
vasculature (Figure S5A). In the pancreas and lungs (Figure 3F;
Figure S5B), parasites were highly enriched across arterial and
venous vessels of all calibers. Although the heart, kidney, and
isc-BAT (Figure 3G; Figure S5C) showed a higher parasite con-
centration in vessels of medium and large caliber, the heart
mostly displayed enrichment in the arterial vasculature, while
the kidneys and isc-BAT showed enrichment in both arterial
and venous vasculature. Finally, in the spleen and lymph nodes
(Figure S5D), parasite concentration was equivalent to the
labeled RBC markers, showing no significant enrichment in
any specific vessel type, while in the liver (Figure 3H), parasites
seemed to be enriched in the arterial vasculature. Although para-
site accumulation in small-diameter vessels of some organs can
be explained by flow conditions characteristic of these organs,
parasite enrichment in large vessels of the heart, kidneys, and
isc-BAT was unexpected given the high flow characteristic of6 Cell Reports 36, 109741, September 21, 2021these vessels. This implies that parasites should exert significant
forces to adhere to ECs.
In conclusion, our in vivo imaging demonstrates that the distri-
bution of parasites across vessels is extremely heterogeneous,
organ dependent, and time dependent. Our results are consis-
tent with the notion that ECs have unique features in each organ,
a concept termed organotypic vasculature (Augustin and Koh,
2017). However, organs with similar parasite distribution (i.e.,
g-WAT and brain, or the pancreas and lungs) do not form equiv-
alent extravascular reservoirs. Thus, additional features should
contribute to reservoir establishment.
Extravascular reservoirs are established before
vascular permeability is compromised
Vascular permeability is typically increased during an infection
and has previously been related to facilitating immune cell
extravasation (Schnoor et al., 2015; Vestweber, 2015). Yet,
changes in vascular permeability have not been previously stud-
ied in a T. brucei infection. We hypothesized that increases in
vascular permeability could regulate parasite extravasation pref-
erentially in the g-WAT and pancreas, allowing tissue tropism. To
investigate vascular permeability, we intravenously injected
mice with CD31 and 70 kDa FITC-Dextran and measured both
the intravascular and extravascular mean fluorescence intensity
(MFI) of FITC-Dextran using established methodology for intra-
vital microscopy (Egawa et al., 2013). At basal conditions, albeit
depending on each organ’s inherent vascular permeability, most
of the FITC-Dextran remains inside blood vessels. If the organ’s
vasculature becomes more permeable, FITC-Dextran will leak
into the organ’s parenchyma (Figure 4A).
The baseline extravascular MFI values in uninfected mice
(controls) for FITC-Dextran depend on each organ’s endogenous
vascular permeability (Figure S6A). g-WAT and isc-BAT were the
least permeable organs, followed by the brain, heart, and lungs.
Spleen, pancreas, and lymph nodes showed intermediate levels
of basal permeability, while the most permeable organs were the
liver and kidneys (Figures S6B and S6C). Organ-specific perme-
ability values in uninfected mice were used to calculate fold
changes in permeability throughout infection (Figure 4).
Vascular permeability increased in all organs throughout infec-
tion (Figure 4B). However, we observed significant differences in
the extent of such increase and in the day at which leakage was
first detected (Figures 4B–4D; Figure S7). In g-WAT and
pancreas, vasculature becomes more permeable from day 5
post-infection, followed by a progressive increase in perme-
ability, and at the end of the infection (day 20), g-WAT is the tis-
sue that shows the highest increase in permeability (14-fold). Fig-
ure 4B shows organs in increasing order of the onset of
increased vascular permeability. Among these organs, the onset
of increased vascular permeability happens on day 3 in spleen
and lymph nodes, on day 5 in liver, kidney, and isc-BAT, on
day 6 in brain and heart, and on day 7 in lungs. For most organs,
maximum permeability is reached close to the end of the infec-
tion (day 20) (Figure 4B; Figure S7). Interestingly, in the brain,
permeability remains low until day 7 and increases dramatically
(2.6- to 5-fold, p < 0.001) on days 8–9, suggesting a significant
disruption of the blood-brain barrier around this time. This is






Figure 4. Changes in vascular permeability
during T. brucei infection
(A) Vascular permeability was measured as an in-
crease in the mean fluorescence intensity (MFI)
emitted by the 70-kDa FITC-Dextran in the extra-
vascular space per organ. Scale bar, 50 mm.
(B) Heatmap of vascular permeability every day of
infection. Vascular permeability is calculated as
the FITC-Dextran MFI in the extravascular space
at each day post-infection relative to FITC-Dextran
MFI in uninfected control (baseline values are
shown in Figure S6). The white dotted lines show
the infection events defined in Figure 1G.
(C) Boxplot showing quantitative values of
vascular permeability corresponding to d5–8.
(D) Graphical representation comparing the time of
increased T. brucei extravasation in each organ
(red dot) and the time of increased vascular
permeability (blue dot).
(E) Heatmaps of vascular permeability upon in-
duction by histamine treatment 2 days prior to
infection up to day 6 post-infection (left), an
extravascular parasite density (right).
(F) Boxplots of extravascular parasite density at
d3–6 post-infection in mice with (values from E,
right panel) or without histamine treatment (values
from Figure 1G).
For all graphs, significance is shown as ***p <
0.001, **p < 0.01, or *p < 0.05. For (B) and (H),
FITC-Dextran was injected intravenously immedi-
ately prior to imaging, and at least 100 fields of
view were used for measurements. Heatmap
shows the mean of these values. All relevant data
used to generate this figure are included in Data S1
(tabs 10–14). See also Figures S6 and S7.
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OPEN ACCESSFITC-Dextran across the brain from day 8 of infection onward
(Figure S7).
When we compare the variation over time of the increase in
vascular permeability of each organ with the extravascular para-
site density,we founda significant correlation formost organs (R2
values ranging between 0.2 and 0.83; p values ranging from 0.04
and <0.001), with the exception of the isc-BAT (R2 = 0.07, p =
0.24) and lymphnodes (R2 = 0.07, p = 0.26). g-WATandpancreas
showed significant correlations throughout the 20 days of infec-
tion (R2 = 0.42, p = 0.002 for g-WAT; R2 = 0.64, p < 0.001 for
pancreas), and the highest fold change in the first parasitemia
wave (Figure 4C). These results suggest that increased vascular
permeability favors parasite extravasation in most organs. How-Cell Rever, we noted that the sharp increase in
parasite density in g-WAT and pancreas
(at day 3 post-infection) precedes the in-
crease in vascular permeability in these
tissues (day 5 post-infection) (Figure 4D).
Thus, parasites preferentially enter and
accumulate in the extravascular spaces
of g-WAT and pancreas before vascular
integrity is compromised. Considering
only days 1–5 of infection, we found no
correlation between extravascular para-
site density and vascular permeability ing-WAT and pancreas, suggesting that tissue tropism is indepen-
dent of vascular permeability.
To further confirm that vascular leakage is not involved in the
early colonization of g-WAT and pancreas, we induced vascular
leakage with histamine, which induces vasodilation and in-
creases leakiness (Egawa et al., 2013) (Figure 4E, left panel).
Upon treatment of mice with histamine 2 days prior to infection
with T. brucei, and during the first 3 days of infection, the 70-
kDa FITC-Dextran presence in the organ’s parenchyma revealed
a generalized increased vascular permeability, leading to a 1.2-
to 5-fold increase in permeability relative to untreated mice dur-
ing the same days post-infection. We capped the analysis to day
6 post-infection, because this is the first time point by which theeports 36, 109741, September 21, 2021 7
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Figure 5. Changes in expression of vascular EC receptors during a
T. brucei infection
(A) Expression of seven EC receptors (P-selectin, E-selectin, ICAM1, ICAM2,
VCAM1, PECAM1, and CD36) measured by intravital imaging after injection of
antibodies coupled to A647 fluorophore. Representative intravital images
relative to g-WAT and pancreas. Scale bars: 50 mm.
(B) Heatmap shows MFI values for each receptor measured in each organ on
uninfected and d6-infectedmice. Measurements are themean value of at least
100 vessels measured per condition.
All relevant data used to generate this figure are included in Data S1 (tabs 15
and 16). See also Figures S8 and S9 and Video S2.
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OPEN ACCESStissue reservoirs are already established. In general, the treat-
ment with histamine results in only a slight increase in the num-
ber of parasites in the parenchyma of most organs (with only the
spleen showing a significant difference relative to untreated
mice, p < 0.01) (Figure 4F). Importantly, the establishment of
the tissue reservoirs in the g-WAT and pancreas does not start
earlier than in non-treated conditions (Figure 4F).
Altogether we conclude that although vascular permeability is
likely a key player for the presence of parasites in the extravas-
cular space of various organs, it does not explain the initial
establishment of the reservoirs in g-WAT and pancreas. These
results suggest that the mechanism for tissue tropism is active
and independent of vascular permeability.8 Cell Reports 36, 109741, September 21, 2021Endothelial adhesion molecules are upregulated during
infection
Our intravital imaging approach showed that parasites frequently
contact ECs (Video S2). ECs are covered by many surface mol-
ecules that play important communication roles with circulating
cells, including leukocytes or cancer cells (Muller, 2002, 2013;
Vestweber, 2015; Wettschureck et al., 2019). Moreover, many
of these adhesion molecules play a role in host-parasite interac-
tions (Smith et al., 2001). To investigate whether EC surface pro-
teins are involved in parasite extravasation, we began by
measuring the protein expression levels of seven EC adhesion
molecules in all the organs of non-infected or infected mice.
We measured P-selectin, E-selectin, ICAM1, ICAM2, VCAM1,
PECAM1, andCD36 by injecting fluorescently labeled antibodies
against those adhesion molecules in non-infected mice and an-
imals at day 6 post-infection and by measuring the fluorescence
intensities by intravital microscopy (Figure 5; Figure S8). The
route of injection (retroorbital or caudal intravenous) did not
result in differently labeled vasculature (Figure S9). The heatmap
shows the intensity of antibody staining in animals infected for
6 days relative to non-infected animals (Figure 5B).
We observed that several adhesion molecules become more
abundant during infection, but the extent of this effect was
very variable among organs and among adhesion molecules.
Of note, E-selectin is the adhesion molecule that is more upregu-
lated during infection (11.3-fold increase on average [p < 0.001],
ranging from 2.5 to 26.7 across organs). In the g-WAT of infected
animals, CD36 and E-selectin were significantly upregulated
during infection (1.9- and 10.6-fold; p < 0.001). In the pancreas,
E-selectin showed the highest upregulation following infection
(13.6-fold, p < 0.001), while P-selectin (1.8-fold, p < 0.001) and
CD36 (1.7-fold, p < 0.001) upregulation were also significant.
We conclude that during a T. brucei infection there are signif-
icant changes in the pattern of expression of the selected EC
adhesion molecules, which indicates organ-specific molecular
alterations in the vasculature during infection.
Adhesive molecules modulate T. brucei tissue
colonization
Next, we investigated the effects of blocking each of these adhe-
sion molecules on parasitemia and mouse survival. In addition,
we targeted P-selectin in combination with E-selectin, because
compensation mechanisms for both molecules have been re-
ported (Hickey et al., 1999). We treated mice with the respective
blocking antibodies for 8 days (from 2 days prior to infection until
6 days post-infection). We monitored peripheral parasitemia
(Figures 6A and 6B). In general, when the effect of blocking a re-
ceptor led to a significant reduction in parasitemia in peripheral
blood, it also led to an increase in mouse survival (Figure 6C).
We observed that blocking E-selectin, P-selectin, ICAM2,
CD36, and PECAM1 allowed 50% of animals to survive past
day 40. Interestingly, simultaneous blocking of P- and E-selectin
appears to have cured animals because no animals died (Fig-
ure 6C). In contrast, blocking ICAM1 and VCAM1 did not change
parasitemia and resulted in a mixed survival phenotype (with
some mice dying at similar times as control mice, while others






Figure 6. Blocking specific vascular EC receptors reduced T. brucei virulence and extravasation
(A) Parasitemia was followed by bioluminescence in mice treated with blocking antibodies 2 days prior to and during the initial 6 days of infection.
(B) Boxplots of mean parasitemia during the first parasite peak (d5–8).
(C) Survival of antibody-treated mice. ECl receptors recognized by antibodies are indicated in the key.
(D) Heatmap of parasite enrichment in multiple organs on d6 post-infection, calculated from the percentage of detected parasites per area in the extravascular
space, in treated versus untreated conditions. Zero was set as the baseline control, and data are plotted in a log10 scale. Each column represents a different
antibody treatment of infectedmice. Graphs in the middle and right panels show the respective quantitative values of parasite density in g-WAT and pancreas. All
other organs are included in Figure S10. Error bars show SD.
(E) Parasitemia was followed by hemocytometer in mice homozygous (CD36/), heterozygous (CD36+/), or wild-type (CD36+/+) for CD36 and mice treated with
blocking antibodies 2 days prior to and during the initial 6 days of infection.
(F) Boxplots of the mean parasitemia during the first peak (d5–8).
(G) Mouse survival as assessed in genetically modified mice.
(legend continued on next page)






OPEN ACCESSWe then tested the role of these adhesion molecules in para-
site extravasation and reservoir establishment. At day 6 post-
infection (day 8 post-treatment), animals were subjected to
intravital microscopy. Extravascular parasite density was
measured by IVM, and data are presented in a heatmap as a
fold change relative to (day 0) control (left panel) and as the per-
centage of values of WT untreated mice (whose value for each
organ is taken as baseline, 100%) (Figure 6D; Figure S10). Inter-
estingly, blocking ICAM1 and VCAM1 resulted in either no
change or an increase in parasite density in most organs (except
the spleen, where parasite density decreased significantly),
while not affecting significantly overall blood parasitemia or
mouse survival. Conversely, blocking PECAM1 had no effect
on the presence of extravascular parasites in most organs (Fig-
ure 6D). The exceptions were the g-WAT and pancreas, where
we observed a 2-fold decrease in extravascular parasite density
(p < 0.001 and p < 0.05, respectively) (Figure 6D). A more pro-
nounced effect was found upon blocking P- and E-selectin,
which resulted in a 2-fold decrease in parasite density (p <
0.001) in most organs and 4-fold decrease (p < 0.001) for g-
WAT and pancreas; a simultaneous block of both receptors re-
sulted in a synergistic effect with an average drop in parasite
density in all organs of 20-fold (p < 0.001), including g-WAT
and pancreas (Figure 6D).
CD36 is the most abundant g-WAT adhesion molecule, and its
blocking resulted in g-WAT-specific phenotype. Althoughparasite
density in the blood decreased 250-fold (Figures 6A and 6B), it led
to a decrease of 2-fold (p < 0.001) in parasite density in the extra-
vascular space of g-WAT, no change in pancreas, and a 1.5- to 3-
fold (p < 0.01) increase in all other organs, including lung and liver,
where CD36 is also highly expressed (Figures 5B and 6D). Consis-
tent with an overall reduction in parasite burden, mice showed
delayed lethality (Figure 6C). To further confirm that CD36 has a
specific role on adipose tissue tropism, we infectedmice in which
one or both CD36 alleles were ablated (CD36+/ and CD36/),
and we followed parasitemia (Figures 6E and 6F), mouse survival
(Figure 6G), and establishment of tissue reservoirs (Figure 6H).
Homozygous knockout mice revealed exactly the same results
as anti-CD36 blocking experiments: (1) reduced parasite density
in adipose tissue and blood, but not in any other solid tissue;
and (2) decreased mouse lethality. Interestingly, these pheno-
types can already be detected with heterozygous mice, high-
lighting the importance of CD36 for T. brucei infection.
Overall, these data show that E- and P-selectins, ICAM2 and
PECAM1, are necessary for parasite extravasation in most or-
gans. Blocking these EC adhesion molecules resulted in a dra-
matic loss of fitness for the parasite population, as observed
by a reduction in parasitemia and a corresponding reduction in
disease burden and mortality for the host. Importantly, CD36 is
specifically required for parasite extravasation in the g-WAT,
but not in other organs, suggesting that adipose tissue tropism(H) Heatmap of parasite enrichment in multiple organs on day 6 post-infection, cal
in mice homozygous or heterozygous for CD36 depletion versus wild-type litterma
Graphs in the middle and right panels show the extravascular parasite density in
For all experiments, measurements correspond to triplicate experiments obtain
surements from at least 12 individual mice. Significance relative to untreated con
relevant data used to generate this figure are included in Data S1 (tabs 17–20). S
10 Cell Reports 36, 109741, September 21, 2021could be mediated by parasite interactions with CD36 at the sur-
face of ECs in adipose tissue vessels.
CD36 facilitates interaction of parasites with ECs
in vitro
To better understand the role of CD36 in the interactions be-
tween parasite and the vasculature, next we used in vitro assays.
First, we asked whether parasites interacted with CD36 immobi-
lized onto a plastic surface using an in vitro assay previously
described (Figure 7A) (De Niz et al., 2016). Half a million
T. brucei bloodstream form parasites were incubated for 1 h in
Petri dishes previously coated with different concentrations of
CD36 (Figure 7B). After washing, the proportion of parasites
that remained attached to the surface was scored by micro-
scopy. We found that up until 50 nM of CD36, only 1%–3% of
parasites remained attached to the surface. However, when
we used 100 nM or more of CD36, we observed that up to
12% of parasites attached (p < 0.001). Interestingly, up to 95%
parasites attached to CD36 (but not to BSA), with the anterior
side of the parasite, including the free flagellum and the parasite
mid-body, suggesting that specific proteins located in this part
of the parasite could mediate the interaction with CD36 (Fig-
ure 7C). Notably, parasites bound only by the flagellar tip were
washed out in all experiments.
To replicate more closely the environment that the parasite
faces in vivo, we established a second in vitro assay using human
umbilical vein ECs (HUVECs) (Figure 7D). We seeded T. brucei
parasites on top of WT, GFP-expressing, or CD36-expressing
HUVEC monolayers for different periods of time and measured
the number of parasites attached after washouts at each time
point. In WT and control GFP-expressing HUVECs, we observed
a baseline attachment of 15% of parasites following 30min of in-
cubation. Differences in attachment across the six time points
measured were not significant in WT and GFP (p = 0.56 and
p = 0.71, respectively). In CD36-expressing cells, a baseline
attachment of 15% was also observed. However, percentages
of attached parasites increased to 21% at 2–4 h and to 28% at
6–8 h. At 6–8 h, the differences relative to the control conditions
(WT andGFP) were significant (p = 0.01) (Figure 7E). As observed
in the assays using recombinant CD36, in EC-based assays, par-
asites preferentially attached to the host cells with the anterior
side of the parasite, while attachment with only the flagellar tip
resulted in removal upon washouts (Figure 7F).
Finally, we investigated whether the expression of CD36 at the
surface of ECs influenced parasite extravasation. We estab-
lished transwell migration assays, whereby we cultured a mono-
layer of WT, GFP-expressing, or CD36-expressing HUVECs on
the base of the top chamber (Figure 7G). On the bottom
compartment, we added HMI-11 media. We then added
T. brucei parasites to the top chamber, and after 1-h incubation,
we counted how many parasites crossed from the top to theculated from the ratio of detected parasites per area in the extravascular space,
tes. Zero was set as the baseline control, and data are plotted in a log10 scale.
g-WAT and pancreas on day 6 post-infection.
ed from 9–12 mice. Heatmaps correspond to the score of at least 100 mea-
trols is shown as ***p < 0.001, **p < 0.01, or *p < 0.05. Error bars show SD. All





Figure 7. CD36 facilitates T. brucei binding to and transmigration through the vascular endothelium
(A) Schematic representation of static binding assay of T. brucei on plastic surfaces coated with recombinant mouse CD36 (rCD36).
(B) Proportion of parasites attached to plastic surface, coated with various concentrations of recombinant mouse CD36 (rCD36). 13 PBS and 1%BSAwere used
as binding controls.
(C) Parasite subcellular regions that bind to plastic surface. Following washouts, the proportion of parasites bound to plastic surface using the full body or the
anterior end (which includes the mid-body and the free flagellum) were quantified.
(D) Schematic representation of static binding assay of T. brucei on WT HUVEC and HUVECs expressing GFP or CD36.
(E) Proportion of parasites attached to HUVECs (WT, GFP-, or CD36-expressing cells). Parasite attachment was quantified at six different time points (0.5, 1, 2, 4,
6, and 8 h). A statistical model considering time was performed.
(F) Parasite subcellular regions that bind to HUVECs. Quantification was as described in (C).
(G) Schematic representation of transwell assay of T. brucei onWT HUVEC and HUVECs expressing GFP or CD36. T. bruceiwere seeded on the top chamber for
1 h.
(H) Proportion of parasites that migrated from the top to bottom chambers of the transwell assay (Boyden chamber). EC barrier consisted of WTHUVEC cells and
HUVEC cells expressing GFP or CD36.
For all panels, ANOVA tests were performed to determine significance. Significance is shown as ***p < 0.001, **p < 0.01, or *p < 0.05. Experimentswere performed
in triplicate, and 100 fields of view were quantified. Error bars show SD. All relevant data used to generate this figure are included in Data S1 (tabs 21–23).
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OPEN ACCESSbottom chamber. We found that in the presence of WT or GFP-
expressing ECs, an average of 20% of parasites transmigrate. In
CD36-expressing HUVECs, it increases up to 27% (p = 0.03
compared with WT) (Figure 7H).Overall, we conclude that T. brucei interacts directly with
CD36, and this interaction may facilitate the crossing of the EC
barrier that separates the blood from the adipose tissue




T. brucei parasites are capable of crossing physical barriers
separating tissues and the vascular system. By studying the
interface between T. brucei and the blood vasculature in different
organs in vivo, we discovered that crossing the vasculature and
colonization of solid tissues is necessary for T. brucei virulence
and greatly affects the disease outcome.
Parasite reservoirs and pathology
Using a combination of bioluminescence and IVM, we confirmed
that the g-WAT is a major parasite reservoir (Trindade et al.,
2016), and we identified a previously unknown reservoir: the
pancreas. Previous works on T. cruzi (Corbett et al., 2002; Dufur-
rena et al., 2017; Martello et al., 2013), Plasmodium (Abhilash
et al., 2016; Glaharn et al., 2018), and Toxoplasma (Nassief Be-
shay et al., 2018) have reported sequestration in pancreatic
blood vessels, pancreatic invasion, and morphological changes
in the pancreas, including acute pancreatitis in humans. The fact
that the pancreas represents one of the largest reservoirs of an
extracellular parasite, such as T. brucei, is puzzling, because
the majority of the organ consists of exocrine tissue that pro-
duces pancreatic enzymes for digestion, including trypsin and
chymotrypsin, amylase, and lipase (Shi and Liu, 2014). Why
such environment is favorable for parasite survival and/or prolif-
eration is unclear.
Comparative analysis of parasite density in several adipose
tissue depots showed that although the g-WAT is the largest
reservoir, overall WATs were significantly enriched in parasites
compared with BATs. BAT and WAT are significantly different
in their transcriptional, secretory, morphological, and metabolic
signatures, and they play different roles (Hull and Segall, 1966;
Rosell et al., 2014; Saely et al., 2012). We hypothesize that the
BAT and WAT present different metabolites to the parasites,
the latter of which favor the parasite reservoir. Moreover, in
this work, we show that during a T. brucei infection, the WAT
and BAT depots respond very different in almost all the features
we assessed. The extent of the translational relevance of our
findings on T. brucei tropism inWAT to humans and other natural
hosts remains relatively unexplored. On this point, several
comparative studies have highlighted similarities and differences
between human and rodent models in terms of adipose tissue
distribution, morphology, and adipokine functions (Zhang
et al., 2018; Bowles and Kopelman, 2001). Nevertheless, WAT
tropism could be an attractive target to explore in future clinical
studies.
Another surprising finding was the highly heterogeneous pat-
terns of parasite distribution in each organ over the course of
infection. The heart, brain, lungs, and kidneys seemed to show
high parasite extravasation late in infection and correlated with
vascular permeability. Interestingly, these four organs have
been associated with specific complications of T. brucei infec-
tion in humans. Conversely, another group of organs (liver,
spleen, and lymph nodes) showed high extravascular enrich-
ment early in infection. These organs are known to filter blood
and/or are secondary lymphoid organs where immune re-
sponses can be initiated and maintained. Research in various
pathogens has shown that early interactions with these organs12 Cell Reports 36, 109741, September 21, 2021ultimately lead to pathology. Such pathology may involve organ
enlargement and remodeling, including the loss of specific areas
necessary for the generation of adequate immune responses
(Cadman et al., 2008; Engwerda et al., 2005; Magez et al.,
2020; Martin-Jaular et al., 2011; Oster et al., 1980; Urban et al.,
2005). In our work, we observed that this early invasion resulted
in very high vascular permeability in the liver and significant
enlargement of the spleen and lymph nodes. Altogether, at ter-
minal points of infection, vascular pathology as assessed by
leakiness is severe in most organs. Although a single cause of
death is difficult to pinpoint, the various rodents analyzed show
severe pathology in multiple organs, and it is possible that death
might be because of multi-organ failure.
Importance of vasculature in parasite virulence
Observation of T. brucei interactions with blood vessels of the
pancreas and WAT led us to hypothesize that parasites could
interact with adhesion molecules at the surface of ECs, favoring
transmigration. Blocking three different surface adhesion mole-
cules in the first week of infection (E- and P- selectin, ICAM2,
and PECAM1) resulted in a global reduction of parasite density
in the blood and solid tissues, suggesting that parasites could
becomemore vulnerable to the immune systemwhen interaction
with vasculature is blocked. Given the role of these receptors in
leukocyte migration, we cannot exclude that blocking antibodies
might affect leukocyte function, which could result in a stronger
immune response in the blood. Importantly, the consequence of
the 8-day antibody treatment was that animals survived much
longer, and some even appear to have been cured. These results
suggest that the parasite-vasculature interaction is a determi-
nant for parasite virulence.
Although treatment against E- and P-selectin and ICAM2 had
a global effect on parasite traversal, blocking CD36 (or geneti-
cally ablating it) resulted in reduced extravascular T. brucei den-
sity in the g-WAT. This suggests that CD36 specifically favors
parasite extravasation in adipose tissue. The in vitro assays
confirmed that T. brucei interacts with CD36 and also CD36
parasite transmigration through ECmonolayers. We hypothesize
that CD36 favors extravasation inWAT. In CD36-blocking exper-
iments, the spleen, liver, and lymph nodes were highly parasit-
ized, suggesting these organs could play a role in eliminating
parasites that could not extravasate. Abrogation of CD36-medi-
ated sequestration of Plasmodium-infected hosts also results in
increased parasite density in the spleen, because they are more
readily eliminated by this lymphoid organ (Fonager et al., 2012;
De Niz et al., 2016).
Taken together, we propose a model for adipose tissue
tropism whereby T. brucei frequently engages with EC surface
proteins as parasites travel in the vasculature. Such interactions
can be mediated by several adhesion molecules (CD36, ICAM2,
E- and P-selectins). In the vasculature of the g-WAT, in addition
to ICAM2, PECAM1, E-selectin, and P-selectin, the high expres-
sion of CD36 facilitates stronger interactions with T. brucei,
which may direct or slow down parasites toward a putative
crossing site, thus favoring extravasation. When adhesion mole-
cules are blocked, T. brucei interactions with ECs are reduced,
interfering with the normal extravasation of parasites. This re-
sults in more parasites being eliminated from the circulation
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OPEN ACCESSeither by systemic immune responses and/or by the spleen.
Remarkably, we unequivocally showed that interfering with
host vasculature reduced pathology and mortality. Thus, phar-
macological targeting of the parasite-EC interface may pave
the way to the development of future therapies to tackle this
medically relevant neglected tropical disease.STAR+METHODS
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Calvo-Alvarez, E., Cren-Travaillé, C., Crouzols, A., and Rotureau, B. (2018). A
new chimeric triple reporter fusion protein as a tool for in vitro and in vivomulti-
modal imaging to monitor the development of African trypanosomes and
Leishmania parasites. Infect. Genet. Evol. 63, 391–403.
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(2020). Intravital imaging of host-parasite interactions in organs of the thoracic
and abdominopelvic cavities. Cell. Microbiol. 22, e13201.
Doyle, T.C., Burns, S.M., and Contag, C.H. (2004). In vivo bioluminescence im-
aging for integrated studies of infection. Cell. Microbiol. 6, 303–317.
Dufurrena, Q., Amjad, F.M., Scherer, P.E., Weiss, L.M., Nagajyothi, J., Roth, J.,
Tanowitz, H.B., and Kuliawat, R. (2017). Alterations in pancreatic b cell function
and Trypanosoma cruzi infection: evidence from human and animal studies.
Parasitol. Res. 116, 827–838.
Egawa, G., Nakamizo, S., Natsuaki, Y., Doi, H., Miyachi, Y., and Kabashima, K.
(2013). Intravital analysis of vascular permeability inmice using two-photonmi-
croscopy. Sci. Rep. 3, 1932.
Engwerda, C.R., Beattie, L., and Amante, F.H. (2005). The importance of the
spleen in malaria. Trends Parasitol. 21, 75–80.
Fernandes, M.C., and Andrews, N.W. (2012). Host cell invasion by Trypano-
soma cruzi: a unique strategy that promotes persistence. FEMS Microbiol.
Rev. 36, 734–747.
Fonager, J., Pasini, E.M., Braks, J.A.M., Klop, O., Ramesar, J., Remarque,
E.J., Vroegrijk, I.O.C.M., van Duinen, S.G., Thomas, A.W., Khan, S.M., et al.
(2012). Reduced CD36-dependent tissue sequestration of Plasmodium-in-
fected erythrocytes is detrimental to malaria parasite growth in vivo. J. Exp.
Med. 209, 93–107.
Franke-Fayard, B., Fonager, J., Braks, A., Khan, S.M., and Janse, C.J. (2010).
Sequestration and tissue accumulation of human malaria parasites: can we
learn anything from rodent models of malaria? PLoS Pathog. 6, e1001032.
Glaharn, S., Punsawad, C., Ward, S.A., and Viriyavejakul, P. (2018). Exploring
pancreatic pathology in Plasmodium falciparum malaria patients. Sci. Rep. 8,
10456.
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Blocking antibody Mouse IgG1 K isotype
control (P3.6.2.8.1)
eBioscience, ThermoFisher Cat# 16-4714-82; RRID: AB_470161
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pLenti-C-mGFT-P2A-Puro OriGENE PS100093
Cd36 (NM_007643) Mouse Tagged ORF
Clone Lentiviral Particle
OriGENE MR227663L4
(Continued on next page)
e1 Cell Reports 36, 109741, September 21, 2021
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Software and algorithms





Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Luisa
Miranda Figueiredo (lmf@medicina.ulisboa.pt).
Materials availability
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Data and code availability
d All data used for the generation of figures in this paper has been included in Data S1.
d This paper does not report original code.
d Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals used
Animal experiments were performed according to EU regulations and approved by the Animal Ethics Committee of Instituto de Me-
dicina Molecular (IMM) (AEC_2011_006_LF_TBrucei_IMM). Mice used across this study included wild-type male C57BL/6J mice,
and C57BL/6 Albino obtained from Charles River, France. Transgenic B6.129S1-Cd36tm1Mfe/J (CD36/) mice were obtained
from The Jackson Laboratory. Breedings were generated in-house at IMM. A homozygous KO line was kept over multiple genera-
tions. A heterozygous (CD36+/) line was generated by crossing CD36/mice with C57BL/6J mice, and a homozygous CD36+/+ line
was generated through backcrossing. Mice were backcrossed over multiple generations, and littermates of all 3 genotypes were
used throughout this work. All mice were 6–9 weeks old males, with an average weight ranging between 25 and 30 g.
Trypanosoma brucei parasites and infections
Mice were infected by intraperitoneal injection of 2,000 T. brucei AnTat 1.1E chimeric triple reporter parasites (Calvo-Alvarez et al.,
2018) expressing the red-shifted firefly luciferase protein PpyREH9, TdTomato and ty1. For parasite counts, blood samples were
taken daily by tail vein puncture, using 1ml of blood diluted in 200 ml of HMI11 medium, and 10 mm loaded in a hemocytometer for
parasite quantification. For mouse survival, mice were followed up until clinical signs indicating no recovery. After determining the
time of highest disease recrudescence in the survival experiments, all other experiments were capped to 20 days of infection.
HUVECs cell culture
Human umbilical vein ECs (HUVECs – Lonza, C2519A) were routinely cultured following the manufacturer’s guidelines at 37C and
5% of CO2 with complete medium EGM-2 Bulletkit (Lonza, CC-3162) without antibiotics. All the experiments were performed be-
tween passages 2 and 4.
When passaging HUVECs for experiments, cells were washed twice in sterile PBS (137mM NaCl, 2.7mM KCl, 4.3mM
Na2HPO4, 1.47mM KH2PO4, pH7.4) and then incubated for 5min in TrypLE Express Enzyme (1X) (Alfagene, 12605028) at
37C, 5% CO2. When 95% of the cells detached, complete medium was added to each flask to inhibit the activity of the TrypLE
Express Enzyme and the cell suspension was transferred into a falcon tube. Cells were then centrifuged at 700rpm for 5min at
10C and the pellet re-suspended in fresh complete medium. HUVECs were then seeded at the desired concentration, depend-
ing on the experiments.
HUVECs viral transduction
Replication-incompetent lentiviruses were produced by transient transfection of HEK293T co-transfected with the viral packaging
vector D8.9 and the viral envelope vector VSVG. Medium was replaced with fresh culture medium 4-6h post transfection. 48h after
post transfection, lentiviral particles were concentrated from supernatant by ultracentrifugation at 90000 g for 1h30 and re-sus-
pended in 0.1% BSA PBS. HUVECs were transduced 24h after seeding with 1% lentiviral plasmids containing GFP (control)
(pLenti-C-mGFT-P2A-Puro, Cat # PS100093, Origene) or CD36-GFP (NM_007643, Cat # MR227663L4, Origene) sequences. 24hCell Reports 36, 109741, September 21, 2021 e2
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and then processed for T. brucei co-culture and imaging.
METHOD DETAILS
Bioluminescence imaging (in vivo and ex vivo)
For whole body imaging, infected mice were injected with 200 ml of RediJect D-luciferin (Xenolight, Perkin Elmer) prior to imaging.
All measurements were performed in an IVIS Lumina imaging system. A kinetic curve was established to determine the peak of
bioluminescence, which was found to be at 10 minutes post-injection, with a plateau lasting a further 10 minutes. For in vivo im-
aging, mice were anaesthetized with Isofluorane (Isotroy) and imaged using an exposure time of 1 minute and a FOV D (12.5 3
12.5 cm). For ex vivo imaging of non-perfused organs, mice were injected with RediJect as described above, and sacrificed using
CO2 within 3 minutes following this injection. Organs were then extracted, washed in 1x PBS, and placed in a plastic Petri dish for
imaging at the IVIS Lumina instrument, using an exposure time of 1 minute and a FOV C (10 3 10 cm). For ex vivo imaging of
perfused organs, mice were injected with RediJect as described above, and sacrificed using CO2 within 3 minutes following
this injection. The chest was then exposed, the inferior vena cava was cut, and the heart was injected with 40 mL of warm 1x
PBS. Organs were then imaged as described above. Image acquisition was obtained, and image analysis performed using the
Living Image  software version 3.0.4.6. For all bioluminescence measures, the results of 9 animals (3 biological replicates in trip-
licate) are expressed.
Intravital and ex vivo imaging
For intravital imaging, surgeries were separately performed in the brain; the lungs and heart; the liver; the pancreas, spleen and kid-
ney; the adipose tissues and lymph nodes, as described in DeNiz et al. (2019a, 2019b, 2019c, 2020). Briefly, micewere anaesthetized
with a mixture of ketamine (120 mg/kg) and xylazine (16 mg/kg) injected intraperitonially. After checking for reflex responses and
ensuring none occurred, mice were intraocularly injected with Hoechst 33342 (stock diluted in dH2O at 100 mg/ml; injection of
40 mg/kg mouse), 70 kDa FITC-Dextran (stock diluted in 1x PBS at stock concentration of 100 mg/ml; injection of 500 mg/kg),
and vascular markers of interest conjugated to A647 (CD31 (Biolegend, used at 20 mg), Ephrin B2 (R&D systems, used at 20 mg),
Eph-B4 (R&D systems, used at 20 mg), or VEGFR3 (R&D systems, used at 20 mg). A temporary glass window (Merk rectangular cover-
glass, 100mmx 60mmor circular coverglass (12mm)) was implanted in each organ, and secured either surgically, with surgical glue,
or via a vacuum, in order to enable visualization of the organ surface.
For intravital microscopy, all imaging relative to parasite quantifications, vascular density and vascular leakage was done in a
Zeiss Cell Observer SD (spinning disc) confocal microscope (Carl Zeiss Microimaging, equipped with a Yokogawa CSU-X1
confocal scanner, an Evolve 512 EMCCD camera and a Hamamatsu ORCA-flash 4.0 VS camera) or in a 3i Marianas SDC (spinning
disc confocal) microscopy (Intelligent Imaging Innovations, equipped with a Yokogawa CSU-X1 confocal scanner and a Photomet-
rics Evolve 512 EMCCD camera). Laser units 405, 488, 561 and 640 were used to image Hoechst in nuclei, extravascular and
intravascular FITC-Dextran, TdTomato in T. brucei, and CD31, respectively. The objective used to image vascular density, vascular
leakage, and proportion of intravascular and extravascular parasites was a 40x LD C-Apochoromat corrected, water immersion
objective with 1.1 NA and 0.62 WD. The objective used to classify T. brucei movement phenotypes was a 100x plan-apochromat,
oil immersion objective with 1.4 NA and 0.17 WD. Between 20 and 100 images were obtained in any one time lapse, with an acqui-
sition rate of 20 frames per second. For vascular density measurements and parasite quantification, in order to gain access to the
full organ, we performed ex vivo imaging from different organ regions. For this, we performed z stacks consisting of 16 stacks
covering up to 200 mm of tissue depth. For all acquisitions, the software used was ZEN blue edition v.2.6 (for the Zeiss Cell
Observed SD) allowing export of images in .czi format, and 3i Slidebook reader v.6.0.22 (for the 3i Marianas SD), allowing export
of images in TIFF format.
Intravascular and extravascular parasite quantification
In order to quantify intravascular and extravascular parasites, we took as reference, the vascular marker CD31-A647 and 70 kDa
FITC-Dextran, and we quantified numbers of T. brucei parasites within the confines of the regions marked by the vascular marker,
and numbers of parasites outside these regions. We then normalized the total quantity to numbers per mm2 so as to be able to
compare both measurements. Measurements were repeated throughout 20 days of infection, and at least a total of 100 fields of
view were quantified.
Vascular density and diameter quantification
In order to quantify vascular density, we took as reference the vascular marker CD31-A647 and 70 kDa FITC-Dextran. We obtained
100 fields of view, and for each field of view the total area was defined as 100%. Using the CD31 signal we were able to segment out
the vascular regions using Fiji software. We calculated the percentage of vascular area covered using the following formula: AV% =
Av 3AT%
AT
, where AT is the total area of the field of view, AT% is 100, and ATv is the total area marked by CD31. Vascular density mea-
surements were performed throughout 20 days of infection. Vessel diameters were measured using Fiji.e3 Cell Reports 36, 109741, September 21, 2021
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Inorder toquantify vascularpermeability changes,we tookas reference themarker70kDaFITC-Dextranaspreviouslypublishedmeth-
odology (Egawa et al., 2013). We measured FITC-Dextran in intravascular and extravascular regions in uninfected mice, and then at
each time post-infection with T. brucei. The permeability ratio was calculated using the following equation: Permeability Ratio Dn =
Mean MFIDn
Mean MFI D0
, wheremeanMFIDn is the extravascularMFI at a specificDay n, and themeanMFID0 is the extravascularMFI in uninfected
mice (Day 0). To induce vascular hyper-permeability, 5 mg/ml of histamine (Sigma-Aldrich) were prepared in 1 x PBS, and 200 ml were
injected intravenously every 2 days, starting 2 days prior to infection.
Erythrocyte labeling and parasite quantification normalization by vascular type
To quantify and normalize parasite numbers per vascular type, red blood cells were extracted from uninfected mice, and pre-labeled
ex-vivo with intracellular dyes CFDA-SE or DDAO-SE as previously described (Theron et al., 2010). The required volume of erythro-
cytes at 5% hematocrit were resuspended in 500 ml HMI11. RBCs were centrifuged and the pellet resuspended either in 20 mM
carboxfluorescein diacetate succinimidyl ester (CFDA-SE) (Invitrogen), or 10 mM 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-
2-one) succinimidyl ester (DDAO-SE) (Invitrogen) in HMI11 and incubated for 20 min at 37C. The suspension was washed 3x in
HMI11, and resuspended at concentrations equaling those observed for parasites at each day post-infection. The labeled RBCs
were then injected into infected mice. The number of RBCs per vessel type were quantified, and the number of parasites expressed
as a percentage of labeled RBCs in any one vessel as follows:
Relativeparasite % Dn =
ParasitenumbersDn 3 labeledRBCT%
labeledRBCnumbersDn
The value of Relative parasite % at Day n (Dn) was plotted and color coded in heatmaps based on total vasculature, arterial vascu-
lature, or venous vasculature.
Labeling endothelial receptors
To investigate the relative expression of EC receptors in different organs, we intravenously injected 20 mg of antibodies against E-
selectin, P-selectin (BD PharMingen), ICAM1, ICAM2, PECAM1, CD36 (BioLegend) and VCAM1 (Invitrogen) conjugated to FITC
(VCAM1) or A647 (all other antibodies), into uninfected or day 6 infected mice, as previously described in the context of parasitology
for CD31 (Hopp et al., 2015). WemeasuredMFIs of at least 100 different vessels per organ in 3 separatemice using an LSM710 Zeiss
microscope, a 40x objective (1.3 NA).
Blocking endothelial receptors
To investigate the effects of blocking various EC receptors, antibodies used included RB40.34 against P-selectin (BD Biosciences,
30 mg per mouse); P2H3 against E-selectin (R&D systems, 20 mg per mouse), a 1:1 combination of both; CBR IC2/2 against ICAM2
(Invitrogen, 20 mg per mouse); YN1/1.7.4 against ICAM1 (eBioscience, 20 mg per mouse); CD31 antibody (abcam, 20 mg per mouse);
and 185-1G2 against CD36 (Abcam, 20 mg per mouse) blocking antibodies were used. Mouse IgG1 and IgG2 isotype controls were
used as controls (eBioscience). Antibodies were injected intravenously daily by tail vein injection, starting two days prior to infection,
and continuing until day 6 post-infection.
Recombinant CD36 binding assays
For in vitromeasurement of T. brucei attachment to CD36, we coated dishes with recombinant mouse CD36/Fc chimera (R&D). Trip-
licate plastic dishes were prepared for each concentration. They were first washed with 1x PBS, and then blocked with 1% (wt/v)
bovine serum albumin (BSA) at 4C overnight. After washing once with 1x PBS, dishes were coated with recombinant mouse
CD36 (2nM, 5nM, 10nM, 50nM, 100nM and 200nM), or with 1x PBS (control 1) or 1x PBS containing 1%BSA (cell culture grade; con-
trol 2) for 3h at 37C in a cell culture incubator. Following this time, plates were washed 3 times and incubated again with 1% BSA in
PBS for 30 minutes. One million T. brucei in HMI-11 were overlayed on the dishes for 1h. After 1h, total parasites were quantified by
microscopy prior to performingwashouts with fresh HM1-11media. After washouts, bound parasiteswere quantified bymicroscopy.
Each condition was done in triplicate and each experiment repeated 3 times.
CD36 binding assays in HUVECs
T. brucei parasites were diluted to a concentration of 0.5 million parasites per ml, and 1ml was overlayed on wells in 24-well plates
containing control andCD36-expressing HUVECs for 0.5, 1, 2, 4, 6 and 8 hours. Separatewells were used for each time point. At each
time point, total parasites were quantified by microscopy prior to performing washouts. After washouts to remove any unbound par-
asites, attached parasites were quantified by microscopy.
CD36 transmigration assays in HUVECs
For transmigration assays, a QCM chemotaxis cell migration assay (24 well-plates, 3 mm) (MERCK, ECM 504) was used. WT, GFP-
and CD36-expressing HUVECs were seeded in the base of the upper chamber of the transwell set, in complete medium. The
lower chamber was also filled with complete medium. Half a million T. brucei parasites suspended in 250 ml of HMI-11 were over-Cell Reports 36, 109741, September 21, 2021 e4
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in the upper and lower chambers by microscopy. At 1h post-co-culture, parasites in the upper and lower chambers were again
quantified.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were displayed in graphs and heatmaps generated using Prism 9 software (GraphPad). Means, medians, survival, correlation
tests, comparison tests, and error measures were calculated from triplicate experiments with 3 biological replicates each, and/or at
least 100 images per condition. For comparisons of bioluminescence measures between organs of different groups we performed
multiple t tests in addition to a one-way ANOVA (differences were considered significant when p < 0.05). Pearson correlations mea-
sures (R), and R2 values were calculated to determine the strength of linear association between parasite density and either vascular
permeability or vascular density. For comparison of proportions between parasites in vessels of different diameters and proportions
in vessels of equal diameter across vascular groups, a linear model was performed, and p values < 0.05 were considered significant.
For comparisons of survival, a log-rank (Mantel-Cox) test was performed, and p values < 0.05 were considered significant. Statistical
details of experiments are included in the figure legends, the results section, and a Supplementary Table excel file. All data used for
the generation of the figures is included as a supporting file.e5 Cell Reports 36, 109741, September 21, 2021
